Patel Sujal M

CEO, President, and Secretary, Director, 10% OwnerNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Aug 8, 2022
Net Buying
Open-Market Buys
$146K
Open-Market Sells
$0
Net Open-Market Flow
$146K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2022Buy(P)8K$2.93$24K10.0M
Aug 5, 2022Buy(P)42K$2.92$122K10.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-22-000089) within minutes of acceptance. Every field above traces to the original document. Verify it directly: